Ekso Bionics (NASDAQ:EKSO) Stock Price Crosses Above Fifty Day Moving Average of $2.01

Ekso Bionics Holdings, Inc. (NASDAQ:EKSOGet Rating)’s stock price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $2.01 and traded as high as $2.32. Ekso Bionics shares last traded at $2.21, with a volume of 10,073 shares changing hands.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. HC Wainwright cut their price objective on shares of Ekso Bionics from $11.00 to $9.00 and set a “buy” rating for the company in a research report on Friday, July 29th. StockNews.com assumed coverage on shares of Ekso Bionics in a research report on Saturday. They issued a “sell” rating for the company.

Ekso Bionics Stock Down 1.3 %

The company has a debt-to-equity ratio of 0.06, a quick ratio of 7.48 and a current ratio of 8.16. The firm’s 50-day moving average is $2.01 and its 200 day moving average is $2.19.

Ekso Bionics (NASDAQ:EKSOGet Rating) last issued its quarterly earnings results on Thursday, July 28th. The company reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.01. Ekso Bionics had a negative net margin of 94.39% and a negative return on equity of 35.11%. The firm had revenue of $3.47 million during the quarter, compared to analyst estimates of $3.49 million. During the same quarter in the prior year, the business posted ($0.26) earnings per share. Research analysts anticipate that Ekso Bionics Holdings, Inc. will post -1.04 EPS for the current year.

Institutional Investors Weigh In On Ekso Bionics

Several large investors have recently made changes to their positions in EKSO. Golden State Wealth Management LLC acquired a new stake in shares of Ekso Bionics in the fourth quarter worth $41,000. Essex Investment Management Co. LLC acquired a new stake in shares of Ekso Bionics in the first quarter worth $484,000. Finally, Renaissance Technologies LLC increased its position in shares of Ekso Bionics by 153.4% in the second quarter. Renaissance Technologies LLC now owns 44,606 shares of the company’s stock worth $74,000 after acquiring an additional 27,006 shares in the last quarter. Institutional investors and hedge funds own 12.47% of the company’s stock.

Ekso Bionics Company Profile

(Get Rating)

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.

Featured Stories

Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.